Newsletter Subscription


Wednesday, May 27, 2015


Implant Sciences Signs Testing Agreements for Quantum Sniffer QS-B220

  • Explosives and Narcotics Trace Detector to Be Deployed at Airports and Air Cargo Facilities
Wilmington, MA - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced it has signed agreements with key end-user sites in the United States, Asia, and South America to test its newly launched Quantum Sniffer(TM) QS-B220 bench-top explosives and narcotics trace detector. The systems will be deployed in actual operational environments in both airport security and air cargo screening facilities.

"We are pleased with the enthusiastic response the QS-B220 is receiving from the user community. Containing no radioactive materials, Implant Sciences' products screen passengers and cargo without health or environmental risks," stated Implant Sciences CEO, Glenn D. Bolduc.

Related Research on ASDReports.com:
Global LiDAR Market 2014-2018

Todd Silvestri, Vice President of Product Development added, "The QS-B220 has been designed to meet or exceed all TSA requirements. With automatic calibration, high throughput, and low maintenance needs, the system is ideally suited for security screening applications."

Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.

Source : Implant Sciences Corp.

Published on ASDNews: Jun 28, 2011

 

International Port Security Conference

Jun 3 - 4, 2015 - London, United Kingdom

Register More info


© 2004-2015 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs

zpsk